V. Gruenvald

Papers

Total Citations

514

H-Index

About

V. Gruenvald is a leading figure in oncology, with a primary focus on genitourinary malignancies, particularly renal cell carcinoma (RCC). Their most impactful contribution is the authorship of the landmark "Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up," a seminal work with over 500 citations that has shaped international standards for managing this complex disease. This guideline synthesizes evidence-based approaches to diagnosis, surgical intervention, systemic therapies, and long-term surveillance, directly influencing clinical decision-making worldwide. Gruenvald’s work has been instrumental in translating emerging research into practical protocols, bridging the gap between clinical trials and everyday patient care. Beyond this cornerstone publication, their research spans prognostic modeling, biomarker discovery, and the optimization of targeted and immunotherapeutic strategies for advanced RCC. With a career dedicated to improving outcomes for kidney cancer patients, Gruenvald is recognized as a key opinion leader whose guidelines remain a vital resource for oncologists, urologists, and researchers striving to refine treatment paradigms and enhance survival rates.